C. Mattson

A new spectrophotometric assay for 2',3'-cyclic nucleotide 3'-phosphohydrolase activity in nervous tissue.

C. E. Dreiling, C. Mattson, 1980, Analytical biochemistry.

The Effects of Epoprostenol on Drug Disposition II: A Pilot Study of the Pharmacokinetics of Furosemide with and without Epoprostenol in Patients with Congestive Heart Failure

V. Schmith, L. D. Carlton, C. Mattson, 1996, Journal of clinical pharmacology.

Synergism between Tissue-Type Plasminogen Activator and a Genetically Engineered Variant Lacking the Finger Domain, the Growth Factor Domain and the First Kringle Domain

C. Sterky, G. Pohl, K. Wikström, 1991, Thrombosis and Haemostasis.

AMCP Partnership Forum: Driving New Advances in Dyslipidemia Management

S. Martin, J. Saseen, Greg Low, 2016, Journal of managed care & specialty pharmacy.

Anti-coagulant and anti-thrombotic effects of some protease inhibitors.

S. Nilsson, E. Eriksson, C. Mattson, 1982, Folia haematologica.

The Effects of Epoprostenol on Drug Disposition I: A Pilot Study of the Pharmacokinetics of Digoxin with and without Epoprostenol in Patients with Congestive Heart Failure

V. Schmith, C. Mattson, J. Patterson, 1996, Journal of clinical pharmacology.